Hormone Replacement Therapy
Weight Management
Weight Maintenance
5,000+ members
Provider-led care
Care personalized to perimenopause and menopause
Josie

Microdosing Semaglutide Chart: A Monthly Dose Guide For Josie Patients

The Josie Team

The Josie Team

Health & Wellness Editors

Dr. Rida Asghar

Medically reviewed by

Dr. Rida Asghar

MBBS, OB/GYN Resident Physician

Published March 12, 2026·Updated July 1, 2026·5 min read

Website content is for informational purposes only and is not medical advice. Always talk with a licensed medical provider about your care options.

Compounded GLP-1 medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before marketing. Compounded medications are not the same as FDA-approved generics. Josie is not a compounding pharmacy; if prescribed, compounded medications are prepared by a licensed compounding pharmacy.

Wegovy and Ozempic are registered trademarks of Novo Nordisk. Zepbound and Mounjaro are registered trademarks of Eli Lilly and Company. Josie is not affiliated with, endorsed by, or sponsored by either company.

A semaglutide microdosing chart that supports comfort, longevity, and gentle month-to-month increases.

If you’re starting compounded semaglutide for longevity and wellness, a microdosing semaglutide chart can make the process much easier to follow. For many women in perimenopause, menopause, and postmenopause, gradually increasing the dose can help minimize side effects like nausea and digestive discomfort while supporting appetite regulation and long-term metabolic stability.

Unlike traditional protocols that begin at 0.25 mg weekly, microdosing may begin as low as 0.05 mg. This gives the body time to adjust before moving higher, which can make the experience feel more comfortable and sustainable.

This gradual approach is part of a broader hormone-aware GLP-1 microdosing strategy used during midlife metabolic changes.

What Is a Microdosing Semaglutide Chart?

A microdosing semaglutide chart is a step-by-step monthly dosing progression guide that starts low and increases gradually over time.

The goal is to help the body adjust comfortably, especially for patients who may be sensitive to GLP-1 medications or prone to nausea and digestive side effects. Instead of jumping to the standard starting dose right away, microdosing allows a slower on-ramp guided by a medical provider.

Sample Microdosing Semaglutide Chart

MonthDosePurpose
Month 10.05–0.1 mgAllow the body to adapt gently
Month 20.1–0.15 mgBegin mild appetite regulation
Month 30.15–0.2 mgBuild tolerance gradually
Month 40.2–0.25 mgApproach the standard starting dose
Month 5+0.25 mg and abovePersonalized with your provider

This chart shows a gentle month-by-month progression. Dose increases are always customized by the provider and based on how the patient feels.

Microdose vs Standard Semaglutide Titration

Standard semaglutide protocols follow a fixed escalation schedule. A microdosing approach moves through smaller steps and allows more flexibility based on how the patient responds.

StageStandard ProtocolMicrodose Approach
Starting Dose0.25 mg weekly0.05–0.1 mg weekly
4-Week Increase0.5 mg0.05–0.1 mg
8-Week Increase1.0 mg0.1–0.15 mg
12-Week Increase1.7 mg0.15–0.2 mg
Maintenance Range2.4 mg (FDA max)0.25 mg and above, provider-guided
Side Effect RiskHigher during escalationLower with gradual approach

Standard protocol doses reflect the FDA-approved titration schedule for Wegovy, which begins at 0.25 mg weekly and increases every four weeks. Microdose ranges represent provider-guided approaches outside of standard clinical protocols.

Why Follow a Semaglutide Microdosing Schedule?

GLP-1 medications can feel intense if the starting dose is too high. A gradual dosing schedule allows the digestive system and appetite signals to adapt at a comfortable pace.

Benefits often include:

  • Fewer digestive side effects such as nausea and bloating
  • Smoother appetite regulation instead of sudden changes
  • Better long-term consistency with treatment
  • Greater comfort during dose adjustments

For many women in perimenopause and menopause, this slower progression can make the experience feel more manageable.

Semaglutide Microdosing + Healthy Habits = Long Term Wellness

Medication can support your goals. Healthy habits help you sustain them.

At Josie, we encourage focusing on simple foundations:

  • Strength training at least twice per week to protect muscle and metabolism
  • High-protein meals to support recovery and body composition
  • Daily movement like walking, stretching, or low-impact cardio
  • Hydration to support digestion and energy
  • Consistent sleep to support hormones and appetite regulation

These habits do not make the medication “work.”

They help you feel better while you are on it.

Josie's Takeaways

  • A microdosing semaglutide chart helps patients ease into treatment comfortably.
  • Starting with very small doses (0.05 - 0.10 mg) can reduce nausea and digestive side effects.
  • Month-by-month increases are often easier to tolerate than rapid titration.
  • Gradual dosing may be especially helpful for women in perimenopause and menopause.
  • Dosing should always be personalized with a licensed medical provider based on the patient's goals and biological makeup.

Explore Semaglutide Microdosing at Josie

Josie offers compounded semaglutide options for patients who prefer a gradual dosing approach.

At Josie, Dr. Ana Lisa Carr will be your supervising MD.

Further Reading

Microdosing

Microdose GLP-1

Low-dose semaglutide or tirzepatide

$189/mo

Start low and adjust with a licensed provider. A gentler entry point than full-dose therapy for women who want steady, sustainable support.

Start Your Intake

Takes about 5 minutes

Related Articles

Microdosing

$189/mo